Spherix

provides intelligence and market research services for businesses...
Read more
Spherix CEO: Dan Barton

CEO

Dan Barton

CEO Approval Rating

- -/100

2015

PrivateIndependent Company

2836 NAICS listing
Est. Annual Revenue
<$1M
Agree?
Est. Employees
25-100
Agree?
Acquisitions
1

News

Feb 19, 2025
GlobalNewswire
Press Release: Spherix : Spherix Global Insights and the American Kidney Fund Announce Strategic Partnership and Inaugural Initiative to Elevate the Voice of Kidney Patients - Beginning with IgAN Patients
Feb 13, 2025
GlobalNewswire
Press Release: Spherix : Early Launch Metrics Indicate UCB's Bimzelx (bimekizumab) Poised to Disrupt the U.S. Psoriatic Arthritis Market
Nov 15, 2024
StreetInsider
Press Release: Spherix : Hope on the Horizon: Nephrologists Emphasize Need for Innovative C3G Treatments as Novartis and Apellis Prepare Therapies for FDA Submission
Nov 07, 2024
GlobalNewswire
Press Release: Spherix : Spherix Global Insights Focuses on Earlier use of Advanced Treatments in Hidradenitis Suppurativa (HS) as a Catalyst for Better Patient Outcomes
Sep 25, 2024
GlobalNewswire
Press Release: Spherix : Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
Sep 23, 2024
GlobalNewswire
Press Release: Spherix : Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
Sep 12, 2024
StreetInsider
Press Release: Spherix : US Rheumatologists Believe Biogen's Litifilimab Is the Leading SLE Pipeline Asset Poised to Offer Improvement Over Benlysta and Saphnelo Based on Clinical Trial Data
Aug 29, 2024
StreetInsider
Press Release: Spherix : Ipsen's Iqirvo Shows Strong Start in Primary Biliary Cholangitis, Now Faces Rivalry from Gilead's Livdelzi
Aug 28, 2024
StreetInsider
Press Release: Spherix : Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising Advances in Gene Therapies
Jul 24, 2024
StreetInsider
Press Release: Spherix : US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold Agglutinin Disease

Trending Companies